Frédéric Rieux‐Laucat

24.5k total citations · 2 hit papers
124 papers, 7.7k citations indexed

About

Frédéric Rieux‐Laucat is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Frédéric Rieux‐Laucat has authored 124 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Immunology, 34 papers in Molecular Biology and 22 papers in Oncology. Recurrent topics in Frédéric Rieux‐Laucat's work include Immune Cell Function and Interaction (54 papers), Immunodeficiency and Autoimmune Disorders (44 papers) and T-cell and B-cell Immunology (24 papers). Frédéric Rieux‐Laucat is often cited by papers focused on Immune Cell Function and Interaction (54 papers), Immunodeficiency and Autoimmune Disorders (44 papers) and T-cell and B-cell Immunology (24 papers). Frédéric Rieux‐Laucat collaborates with scholars based in France, United Kingdom and United States. Frédéric Rieux‐Laucat's co-authors include Alain Fischer, Françoise Le Deist, Claire Hivroz, Jean‐Pierre de Villartay, Irene Roberts, Klaus‐Michael Debatin, Capucine Pïcard, Geneviève de Saint Basile, Laura Barnabei and Bénédicte Neven and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Frédéric Rieux‐Laucat

117 papers receiving 7.5k citations

Hit Papers

2 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mutations in Fas Associated with Human Lymphoproliferative Syndrome and Autoimmunity

1995 1.0k citations Frédéric Rieux‐Laucat, Françoise Le Deist et al. profile →
NF-κB: At the Borders of Autoimmunity and Inflammation

2021 409 citations Laura Barnabei, Frédéric Rieux‐Laucat et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frédéric Rieux‐Laucat France	42	4.9k	2.8k	1.4k	1.2k	793	124	7.7k
Seon Hee Chang United States	35	8.4k 1.7×	1.9k 0.7×	802 0.6×	1.9k 1.6×	511 0.6×	50	11.4k
Alejandro V. Villarino United States	39	6.4k 1.3×	2.2k 0.8×	657 0.5×	2.7k 2.3×	631 0.8×	64	10.2k
Michel Peuchmaur France	49	1.9k 0.4×	2.0k 0.7×	1.3k 0.9×	1.5k 1.3×	359 0.5×	189	7.6k
Manuela Battaglia Italy	39	5.2k 1.1×	1.2k 0.4×	1.8k 1.3×	1.1k 0.9×	657 0.8×	110	7.8k
Dhavalkumar D. Patel United States	42	3.0k 0.6×	2.3k 0.8×	1.2k 0.8×	795 0.7×	375 0.5×	67	6.7k
Yisong Y. Wan United States	39	5.7k 1.2×	2.5k 0.9×	733 0.5×	1.9k 1.6×	300 0.4×	71	9.0k
Thomas L. Rothstein United States	53	7.1k 1.5×	2.9k 1.0×	471 0.3×	1.3k 1.1×	442 0.6×	205	10.2k
Kim L. Stocking United States	15	4.8k 1.0×	2.7k 1.0×	479 0.3×	2.1k 1.8×	752 0.9×	18	9.6k
Angela M. Thornton United States	39	8.8k 1.8×	1.6k 0.6×	889 0.6×	1.7k 1.5×	449 0.6×	66	11.2k

Countries citing papers authored by Frédéric Rieux‐Laucat

Since Specialization

Citations

This map shows the geographic impact of Frédéric Rieux‐Laucat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Rieux‐Laucat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Rieux‐Laucat more than expected).

Fields of papers citing papers by Frédéric Rieux‐Laucat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Rieux‐Laucat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Rieux‐Laucat. The network helps show where Frédéric Rieux‐Laucat may publish in the future.

Co-authorship network of co-authors of Frédéric Rieux‐Laucat

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Rieux‐Laucat. A scholar is included among the top collaborators of Frédéric Rieux‐Laucat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Rieux‐Laucat. Frédéric Rieux‐Laucat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martin, Emmanuel, Quentin Riller, Aude Magérus, et al.. (2024). Long‐term assessment of haematological recovery following somatic genetic rescue in a MYSM1‐deficient patient: Implications for in vivo gene therapy. British Journal of Haematology. 205(6). 2349–2354. 2 indexed citations

Stolzenberg, Marie‐Claude, Mélanie Parisot, Cécile Masson, et al.. (2024). Study of the potential role of CASPASE-10 mutations in the development of autoimmune lymphoproliferative syndrome. Cell Death and Disease. 15(5). 315–315. 3 indexed citations

Aouba, Achille, Quentin Riller, Guilaine Boursier, et al.. (2023). L’haploinsuffisance de A20 : que doit connaître le clinicien?. La Revue de Médecine Interne. 45(7). 415–422.

Aladjidi, Nathalie, et al.. (2023). Paediatric‐onset Evans syndrome: Breaking away from refractory immune thrombocytopenia. British Journal of Haematology. 203(1). 28–35. 3 indexed citations

Magérus, Aude, Anne Rensing‐Ehl, V. Koneti Rao, et al.. (2023). Autoimmune lymphoproliferative immunodeficiencies (ALPIDs): A proposed approach to redefining ALPS and other lymphoproliferative immune disorders. Journal of Allergy and Clinical Immunology. 153(1). 67–76. 9 indexed citations

Mazerolles, Fabienne & Frédéric Rieux‐Laucat. (2021). PD-L1 is expressed on human activated naive effector CD4+ T cells. Regulation by dendritic cells and regulatory CD4+ T cells. PLoS ONE. 16(11). e0260206–e0260206. 7 indexed citations

Magérus, Aude, et al.. (2021). The genetic landscape of the FAS pathway deficiencies. Biomedical Journal. 44(4). 388–399. 25 indexed citations

Boussier, Jérémy, Nader Yatim, A. Marchal, et al.. (2021). Severe COVID-19 is associated with hyperactivation of the alternative complement pathway. Journal of Allergy and Clinical Immunology. 149(2). 550–556.e2. 25 indexed citations

Courties, Alice, Jérémy Boussier, Jérôme Hadjadj, et al.. (2021). Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients. Scientific Reports. 11(1). 11886–11886. 31 indexed citations

10.

Lévy, E, Marie‐Claude Stolzenberg, Julie Bruneau, et al.. (2016). LRBA deficiency with autoimmunity and early onset chronic erosive polyarthritis. Clinical Immunology. 168. 88–93. 40 indexed citations

11.

Jeremiah, Nadia, Bénédicte Neven, Matteo Gentili, et al.. (2014). Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations. Journal of Clinical Investigation. 124(12). 5516–5520. 393 indexed citations

12.

Haerynck, Filomeen, et al.. (2012). Successful treatment with sirolimus in patients with refractory autoimmune lymphoproliferative syndrome. Journal of Clinical Immunology. 32. 54–55.

13.

Bolze, Alexandre, Minji Byun, David McDonald, et al.. (2010). Whole-Exome-Sequencing-Based Discovery of Human FADD Deficiency. The American Journal of Human Genetics. 87(6). 873–881. 118 indexed citations

14.

Mateo, Véronique, Apiradee Lim, Aude Magérus, et al.. (2008). Human TCR α/β+ CD4−CD8− Double-Negative T Cells in Patients with Autoimmune Lymphoproliferative Syndrome Express Restricted Vβ TCR Diversity and Are Clonally Related to CD8+ T Cells. The Journal of Immunology. 181(1). 440–448. 57 indexed citations

15.

Ruemmele, Frank M., Sylvie Fraïtag, Frédéric Rieux‐Laucat, et al.. (2008). Cutaneous manifestations of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. British Journal of Dermatology. 160(3). 645–651. 85 indexed citations

16.

Rieux‐Laucat, Frédéric. (2006). Le syndrome lymphoprolifératif avec auto-immunité : un défaut hérité ou acquis d’apoptose lymphocytaire. médecine/sciences. 22. 645–649. 3 indexed citations

17.

Buch, Thorsten, Frédéric Rieux‐Laucat, Irmgard Förster, & Klaus Rajewsky. (2002). Failure of HY-Specific Thymocytes to Escape Negative Selection by Receptor Editing. Immunity. 16(5). 707–718. 56 indexed citations

18.

Rieux‐Laucat, Frédéric. (2000). The Fas pathway : signaling of apoptosis. Hématologie. 6(2). 1 indexed citations

19.

Villartay, Jean‐Pierre de, Frédéric Rieux‐Laucat, Alain Fischer, & Françoise Le Deist. (1998). Clinical effects of mutations to CD95 (Fas): relevance to autoimmunity?. Springer Seminars in Immunopathology. 19(3). 301–310. 4 indexed citations

20.

Deist, Françoise Le, Jean‐François Emile, Frédéric Rieux‐Laucat, et al.. (1996). Clinical, immunological, and pathological consequences of Fas-deficient conditions. The Lancet. 348(9029). 719–723. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact